Kevin N. Dack

<i>In vitro</i>and<i>in vivo</i>characterization of PF‐04418948, a novel, potent and selective prostaglandin EP₂receptor antagonist

KJ af Forselles, James Root, Tracey L. Clarke et al. · British Journal of Pharmacology · 2011 · 159 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib

Qinhua Huang, Ted W. Johnson, Simon Bailey et al. · Journal of Medicinal Chemistry · 2014 · 118 citations · Full text

Medicine, Oncology, Pharmacology +14

Discovery of Aryloxy Tetramethylcyclobutanes as Novel Androgen Receptor Antagonists

Chuangxing Guo, Angelica Linton, Susan E. Kephart et al. · Journal of Medicinal Chemistry · 2011 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Dynamic Combinatorial Mass Spectrometry Leads to Inhibitors of a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase

Esther C. Y. Woon, Marina Demetriades, Eleanor A. L. Bagg et al. · Journal of Medicinal Chemistry · 2012 · 53 citations · Full text

Pharmacy, Biochemistry, Chemistry +16

A mild and selective C-3 reductive alkylation of indoles

Julie E. Appleton, Kevin N. Dack, Andrew D. Green et al. · Tetrahedron Letters · 1993 · 50 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10